LFVN Stock Summary and Trading Ideas (Lifevantage | NASDAQ:LFVN)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Lifevantage trades on the NASDAQ stock market under the symbol LFVN.

As of April 14, 2026, LFVN stock price declined to $4.14 with 165,532 million shares trading.

LFVN has a beta of 0.98, meaning it tends to be less sensitive to market movements. LFVN has a correlation of 0.10 to the broad based SPY ETF.

LFVN has a market cap of $52.90 million. This is considered a Micro Cap stock.

Last quarter Lifevantage reported $49 million in Revenue and $.15 earnings per share. This fell short of revenue expectation by $-6 million and missed earnings estimates by -$.03.

In the last 3 years, LFVN traded as high as $27.38 and as low as $3.04.

The top ETF exchange traded funds that LFVN belongs to (by Net Assets): VTI, IWM, VXF, IWO, AVUV.

LFVN has underperformed the market in the last year with a price return of -69.7% while the SPY ETF gained +30.2%. LFVN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -31.5% and -4.3%, respectively, while the SPY returned +0.9% and +6.8%, respectively.

LFVN support price is $3.98 and resistance is $4.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFVN shares will trade within this expected range on the day.